| Ms Nicole Lindmeier, MS | |
|
1829 Denver West Dr, Golden, CO 80401-3120 | |
| (720) 663-0496 | |
| Not Available |
| Full Name | Ms Nicole Lindmeier |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1829 Denver West Dr, Golden, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073381372 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 24403534 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Nicole Lindmeier, MS 1829 Denver West Dr Bldg 27, Golden, CO 80401-3120 Ph: () - | Ms Nicole Lindmeier, MS 1829 Denver West Dr, Golden, CO 80401-3120 Ph: (720) 663-0496 |
News Archive
The Heart Failure Society of America's (HFSA) 13th Annual Scientific Meeting convened Sunday, September 13, 2009 at the Hynes Convention Center in Boston. This three-day meeting - a forum for heart failure specialists to present research findings and advances in treatment - will address emerging trends in research and new developments in the approach to treating patients with this condition.
Work stress, sleep disorders, and fatigue, regarded as non-traditional risk factors for heart attack and stroke, are rising more steeply amongst women than men, according to a new study presented today at the European Stroke Organisation (ESO) Conference.
The use of testosterone assays for patient care and research is on the rise as new research links testosterone to a variety of diseases and conditions. Although the assays are heavily used, discrepancies and inaccuracies in measurements resulting from the various assays are widespread.
As the United States nears its hottest time of the year, scientists are launching a research project into whether the public health impacts of extreme heat will be amplified by the COVID-19 pandemic.
ImmunoCellular Therapeutics, a biotechnology company focused on the development of novel immune-based cancer therapies, today announced that it has developed an innovative method for manufacturing the company's lead product candidate, ICT-107, a dendritic cell-based vaccine for the treatment of glioblastoma multiforme (GBM).
› Verified 3 days ago
Suzanne Sharpe, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1829 Denver West Dr Bldg 27, Golden, CO 80401 Phone: 303-982-6682 | |
Lara Harshfield Slp, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1119 11th St, Golden, CO 80401 Phone: 303-328-7805 | |
Lindsay B Koup, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1829 Denver West Dr # 27, Golden, CO 80401 Phone: 303-982-6500 | |
Lara Kristen Harshfield, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1829 Denver West Dr Bldg 27, Golden, CO 80401 Phone: 303-328-7805 | |
Cindy Dipaola, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1829 Denver West Dr Bldg 27, Golden, CO 80401 Phone: 303-982-1771 | |
Ms. Denise Canonaco, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1829 Denver West Dr # 27, Golden, CO 80401 Phone: 303-982-6500 | |
Paula Jean Glenn, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1829 Denver West Dr, Golden, CO 80401 Phone: 303-982-6500 |